Almirall S.A. (ALM) - Net Assets
Based on the latest financial reports, Almirall S.A. (ALM) has net assets worth €1.48 Billion EUR (≈ $1.72 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.36 Billion ≈ $2.76 Billion USD) and total liabilities (€882.40 Million ≈ $1.03 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Almirall S.A. to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €1.48 Billion |
| % of Total Assets | 62.57% |
| Annual Growth Rate | 5.84% |
| 5-Year Change | 14.23% |
| 10-Year Change | 1.76% |
| Growth Volatility | 31.91 |
Almirall S.A. - Net Assets Trend (2003–2024)
This chart illustrates how Almirall S.A.'s net assets have evolved over time, based on quarterly financial data. Also explore Almirall S.A. asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Almirall S.A. (2003–2024)
The table below shows the annual net assets of Almirall S.A. from 2003 to 2024. For live valuation and market cap data, see how much is Almirall S.A. worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €1.49 Billion ≈ $1.74 Billion |
+1.71% |
| 2023-12-31 | €1.46 Billion ≈ $1.71 Billion |
+10.97% |
| 2022-12-31 | €1.32 Billion ≈ $1.54 Billion |
+2.54% |
| 2021-12-31 | €1.29 Billion ≈ $1.50 Billion |
-1.30% |
| 2020-12-31 | €1.30 Billion ≈ $1.52 Billion |
+1.78% |
| 2019-12-31 | €1.28 Billion ≈ $1.50 Billion |
+7.42% |
| 2018-12-31 | €1.19 Billion ≈ $1.39 Billion |
+5.12% |
| 2017-12-31 | €1.13 Billion ≈ $1.33 Billion |
-25.43% |
| 2016-12-31 | €1.52 Billion ≈ $1.78 Billion |
+3.94% |
| 2015-12-31 | €1.46 Billion ≈ $1.71 Billion |
+9.18% |
| 2014-12-31 | €1.34 Billion ≈ $1.57 Billion |
+50.80% |
| 2013-12-31 | €888.33 Million ≈ $1.04 Billion |
-3.83% |
| 2012-12-31 | €923.67 Million ≈ $1.08 Billion |
+8.07% |
| 2011-12-31 | €854.71 Million ≈ $999.25 Million |
+4.32% |
| 2010-12-31 | €819.30 Million ≈ $957.85 Million |
+9.09% |
| 2009-12-31 | €751.00 Million ≈ $878.00 Million |
-- |
| 2008-12-31 | €0.00 ≈ $0.00 |
-- |
| 2007-12-31 | €573.65 Million ≈ $670.66 Million |
-24.84% |
| 2006-12-31 | €763.21 Million ≈ $892.28 Million |
-15.06% |
| 2005-12-31 | €898.52 Million ≈ $1.05 Billion |
+75.36% |
| 2004-12-31 | €512.38 Million ≈ $599.02 Million |
+13.28% |
| 2003-12-31 | €452.30 Million ≈ $528.79 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Almirall S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 87.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €10.15 Million | 0.68% |
| Common Stock | €25.62 Million | 1.72% |
| Other Comprehensive Income | €869.25 Million | 58.40% |
| Other Components | €583.37 Million | 39.19% |
| Total Equity | €1.49 Billion | 100.00% |
Almirall S.A. Competitors by Market Cap
The table below lists competitors of Almirall S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Atlanta Braves Holdings, Inc. Series C Common Stock
NASDAQ:BATRK
|
$2.63 Billion |
|
Shanghai Zhenhua Heavy Industries Co Ltd A
SHG:600320
|
$2.63 Billion |
|
Hawaiian Electric Industries Inc
NYSE:HE
|
$2.64 Billion |
|
RXO Inc.
NYSE:RXO
|
$2.64 Billion |
|
CLARIANT ADR 1/SF 4
F:CLRS
|
$2.63 Billion |
|
Plug Power Inc
NASDAQ:PLUG
|
$2.63 Billion |
|
Dongguan Yiheda Automation Co. Ltd.
SHE:301029
|
$2.63 Billion |
|
Double Medical Technology Inc
SHE:002901
|
$2.63 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Almirall S.A.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,463,400,000 to 1,488,382,000, a change of 24,982,000 (1.7%).
- Net income of 10,147,000 contributed positively to equity growth.
- Dividend payments of 3,288,000 reduced retained earnings.
- New share issuances of 539,000 increased equity.
- Other comprehensive income decreased equity by 60,213,000.
- Other factors increased equity by 77,797,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €10.15 Million | +0.68% |
| Dividends Paid | €3.29 Million | -0.22% |
| Share Issuances | €539.00K | +0.04% |
| Other Comprehensive Income | €-60.21 Million | -4.05% |
| Other Changes | €77.80 Million | +5.23% |
| Total Change | €- | 1.71% |
Book Value vs Market Value Analysis
This analysis compares Almirall S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.79x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.33x to 1.79x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-12-31 | €5.41 | €12.58 | x |
| 2006-12-31 | €4.59 | €12.58 | x |
| 2007-12-31 | €3.45 | €12.58 | x |
| 2008-12-31 | €4.02 | €12.58 | x |
| 2009-12-31 | €4.51 | €12.58 | x |
| 2010-12-31 | €4.93 | €12.58 | x |
| 2011-12-31 | €5.15 | €12.58 | x |
| 2012-12-31 | €5.33 | €12.58 | x |
| 2013-12-31 | €5.14 | €12.58 | x |
| 2014-12-31 | €7.75 | €12.58 | x |
| 2015-12-31 | €8.46 | €12.58 | x |
| 2016-12-31 | €8.79 | €12.58 | x |
| 2017-12-31 | €6.54 | €12.58 | x |
| 2018-12-31 | €6.34 | €12.58 | x |
| 2019-12-31 | €6.81 | €12.58 | x |
| 2020-12-31 | €6.90 | €12.58 | x |
| 2021-12-31 | €7.19 | €12.58 | x |
| 2022-12-31 | €7.30 | €12.58 | x |
| 2023-12-31 | €7.43 | €12.58 | x |
| 2024-12-31 | €7.04 | €12.58 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Almirall S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.68%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.03%
- • Asset Turnover: 0.41x
- • Equity Multiplier: 1.61x
- Recent ROE (0.68%) is below the historical average (8.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 13.10% | 15.99% | 0.61x | 1.34x | €27.87 Million |
| 2006 | 19.29% | 18.58% | 0.71x | 1.46x | €70.93 Million |
| 2007 | 22.87% | 15.38% | 0.59x | 2.51x | €73.84 Million |
| 2008 | 20.84% | 15.08% | 0.65x | 2.14x | €70.80 Million |
| 2009 | 20.17% | 16.37% | 0.62x | 1.97x | €76.40 Million |
| 2010 | 14.48% | 13.44% | 0.57x | 1.88x | €36.67 Million |
| 2011 | 9.85% | 10.95% | 0.53x | 1.70x | €-1.31 Million |
| 2012 | 8.26% | 10.67% | 0.53x | 1.47x | €-16.08 Million |
| 2013 | -3.80% | -4.51% | 0.42x | 2.00x | €-122.55 Million |
| 2014 | 33.48% | 54.75% | 0.32x | 1.90x | €314.47 Million |
| 2015 | 9.01% | 19.13% | 0.27x | 1.73x | €-14.43 Million |
| 2016 | 4.96% | 9.87% | 0.27x | 1.85x | €-76.55 Million |
| 2017 | -26.81% | -47.54% | 0.29x | 1.92x | €-417.33 Million |
| 2018 | 6.52% | 10.26% | 0.32x | 2.01x | €-41.50 Million |
| 2019 | 8.27% | 12.38% | 0.35x | 1.91x | €-22.11 Million |
| 2020 | 5.70% | 4.60% | 0.70x | 1.76x | €-56.02 Million |
| 2021 | -3.18% | -4.94% | 0.39x | 1.67x | €-169.46 Million |
| 2022 | 0.32% | 0.50% | 0.40x | 1.63x | €-127.59 Million |
| 2023 | -2.63% | -4.30% | 0.38x | 1.62x | €-184.81 Million |
| 2024 | 0.68% | 1.03% | 0.41x | 1.61x | €-138.69 Million |
Industry Comparison
This section compares Almirall S.A.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $309,367,750
- Average return on equity (ROE) among peers: -23.61%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Almirall S.A. (ALM) | €1.48 Billion | 13.10% | 0.60x | $2.63 Billion |
| Faes Farma SA (FAE) | $747.70 Million | 10.65% | 0.79x | $1.50 Billion |
| Labiana Health S.A. (LAB) | $7.74 Million | -115.49% | 6.85x | $32.50 Million |
| Laboratorio Reig Jofre S.A (RJF) | $194.55 Million | 4.17% | 0.65x | $221.39 Million |
| Laboratorios Farmaceuticos ROVI (ROVI) | $287.47 Million | 6.22% | 0.40x | $3.81 Billion |
About Almirall S.A.
Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfecti… Read more